Literature DB >> 34515313

Increasing the scope for 18F-FET PET in pediatric neuro-oncology.

Sohil H Patel1, Prem P Batchala2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34515313      PMCID： PMC8643468          DOI： 10.1093/neuonc/noab221

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   13.029


× No keyword cloud information.
  9 in total

Review 1.  Performance of 18F-fluoro-ethyl-tyrosine (18F-FET) PET for the differential diagnosis of primary brain tumor: a systematic review and Metaanalysis.

Authors:  Vincent Dunet; Christine Rossier; Alfred Buck; Roger Stupp; John O Prior
Journal:  J Nucl Med       Date:  2012-02       Impact factor: 10.057

2.  Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET).

Authors:  Asma Bashir; Sofie Mathilde Jacobsen; Otto Mølby Henriksen; Helle Broholm; Thomas Urup; Kirsten Grunnet; Vibeke Andrée Larsen; Søren Møller; Jane Skjøth-Rasmussen; Hans Skovgaard Poulsen; Ian Law
Journal:  Neuro Oncol       Date:  2019-12-17       Impact factor: 12.300

Review 3.  Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.

Authors:  Jason Fangusaro; Olaf Witt; Pablo Hernáiz Driever; Asim K Bag; Peter de Blank; Nadja Kadom; Lindsay Kilburn; Robert M Lober; Nathan J Robison; Michael J Fisher; Roger J Packer; Tina Young Poussaint; Ludmila Papusha; Shivaram Avula; Alba A Brandes; Eric Bouffet; Daniel Bowers; Anton Artemov; Murali Chintagumpala; David Zurakowski; Martin van den Bent; Brigitte Bison; Kristen W Yeom; Walter Taal; Katherine E Warren
Journal:  Lancet Oncol       Date:  2020-06       Impact factor: 41.316

4.  (18)F-FET-PET guided surgical biopsy and resection in children and adolescence with brain tumors.

Authors:  Martin Misch; Andreas Guggemos; Pablo Hernáiz Driever; Arend Koch; Frederik Grosse; Ingo G Steffen; Michail Plotkin; Ulrich-Wilhelm Thomale
Journal:  Childs Nerv Syst       Date:  2014-09-18       Impact factor: 1.475

5.  The usefulness of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the clinical evaluation of brain tumors in children and adolescents.

Authors:  Veronika Dunkl; Corvin Cleff; Gabriele Stoffels; Natalie Judov; Sevgi Sarikaya-Seiwert; Ian Law; Lars Bøgeskov; Karsten Nysom; Sofie B Andersen; Hans-Jakob Steiger; Gereon R Fink; Guido Reifenberger; Nadim J Shah; Heinz H Coenen; Karl-Josef Langen; Norbert Galldiks
Journal:  J Nucl Med       Date:  2014-12-18       Impact factor: 10.057

6.  Early Postoperative 18F-FET PET/MRI for Pediatric Brain and Spinal Cord Tumors.

Authors:  Lisbeth Marner; Karsten Nysom; Astrid Sehested; Lise Borgwardt; René Mathiasen; Otto Mølby Henriksen; Michael Lundemann; Per Munck Af Rosenschöld; Carsten Thomsen; Lars Bøgeskov; Jane Skjøth-Rasmussen; Marianne Juhler; Anders Kruse; Helle Broholm; David Scheie; Torsten Lauritsen; Julie Lyng Forman; Peder Skov Wehner; Liselotte Højgaard; Ian Law
Journal:  J Nucl Med       Date:  2019-01-25       Impact factor: 10.057

Review 7.  Physics of pure and non-pure positron emitters for PET: a review and a discussion.

Authors:  Maurizio Conti; Lars Eriksson
Journal:  EJNMMI Phys       Date:  2016-05-23

8.  Simultaneous FET-PET and contrast-enhanced MRI based on hybrid PET/MR improves delineation of tumor spatial biodistribution in gliomas: a biopsy validation study.

Authors:  Shuangshuang Song; Ye Cheng; Jie Ma; Leiming Wang; Chengyan Dong; Yukui Wei; Geng Xu; Yang An; Zhigang Qi; Qingtang Lin; Jie Lu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-01-09       Impact factor: 9.236

Review 9.  Diagnostic Performance and Prognostic Value of PET/CT with Different Tracers for Brain Tumors: A Systematic Review of Published Meta-Analyses.

Authors:  Giorgio Treglia; Barbara Muoio; Gianluca Trevisi; Maria Vittoria Mattoli; Domenico Albano; Francesco Bertagna; Luca Giovanella
Journal:  Int J Mol Sci       Date:  2019-09-20       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.